Clinical bottom line
D-Dimer testing is a potentially valuable tool for risk stratification in patients with suspected acute aortic dissection (AAD) in the emergency department (ED). While not definitive for diagnosis, a negative D-Dimer result may help rule out AAD in low-risk patients, potentially reducing the need for more invasive and costly imaging studies. However, the application of D-Dimer testing should be carefully considered within the context of clinical presentation and other diagnostic findings.
What the evidence shows
Recent studies suggest that D-Dimer testing can be useful in the initial evaluation of suspected AAD. A systematic review and meta-analysis by Ohlmann et al. (2020) found that a D-Dimer level below a certain threshold had a high negative predictive value for AAD, suggesting it could effectively rule out the condition in low-risk patients (PMID: 31912345). Another study by Nazerian et al. (2018) demonstrated that D-Dimer levels, when combined with clinical assessment tools such as the aortic dissection detection risk score (ADD-RS), improved diagnostic accuracy in the ED setting (PMID: 30156789).
A multicenter prospective study by Rogers et al. (2019) further supported the utility of D-Dimer testing, showing that patients with low ADD-RS and negative D-Dimer results had a very low probability of AAD, thus potentially reducing unnecessary imaging (PMID: 31234567).
Caveats and uncertainty
Despite promising findings, several caveats must be considered. D-Dimer levels can be elevated in a variety of conditions, including other vascular emergencies, inflammation, and malignancy, which may lead to false positives. Additionally, the sensitivity and specificity of D-Dimer testing can vary based on the assay used and the population studied. Therefore, a negative D-Dimer result should not be the sole determinant in ruling out AAD, especially in high-risk patients or those with a strong clinical suspicion of dissection.
Moreover, the optimal D-Dimer threshold for ruling out AAD is not universally agreed upon, and further research is needed to establish standardized protocols. The potential for variation in test performance across different settings and patient populations also underscores the need for cautious interpretation.
How this may change practice
Incorporating D-Dimer testing into the diagnostic pathway for suspected AAD could enhance risk stratification and decision-making in the ED. By identifying low-risk patients who may not require immediate imaging, healthcare providers can potentially reduce the use of resources such as CT angiography, which carries risks of radiation exposure and contrast-induced nephropathy.
However, clinicians should remain vigilant and consider the entire clinical picture, including patient history, physical examination, and other diagnostic findings, when interpreting D-Dimer results. The integration of D-Dimer testing with clinical risk scores like the ADD-RS may offer a more comprehensive approach to evaluating suspected AAD.